samedan logo
 
 
 
spacer
home > pmps > spring 2009 > hidden danger
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Hidden Danger

Temperature-sensitive pharmaceuticals play a critical role in today’s healthcare. At some point during their development, manufacture and sales, however, nearly all must be transported somewhere. Ensuring the integrity of vaccines and other pharmaceutical products requires strict protocol for packaging and shipment. One commonly used method for maintaining proper temperatures during transportation is dry ice. While it has its strengths, questions are increasingly being raised about the efficacy of this material in the cold chain process.

CASE STUDY

On the evening of 29th April 1998, a Douglas DC-8 cargo airplane was taxiing for takeoff at Brownsville/South Padre Island International Airport in Brownsville, Texas, when all four occupants (three flight crew members and a jumpseat rider) became short of breath. The crew donned oxygen masks, and the captain taxied the plane back to the ramp. The crew members and the jumpseat rider were transported to a hospital where they were examined and released.

There was no damage to the plane, but documents indicated that two shipments containing hazardous materials were loaded on board. The captain was aware of the nature, quantity and location of these items. One shipment consisted of 5,482lbs of frozen shrimp packed in 198 packages, with each package containing 4.85lbs of dry ice, making a total of 960.3lbs of dry ice. The other shipment consisted of 180lbs of paint, a Department of Transportation defined flammable liquid. The packages containing the dry ice and the paint were located in the main cargo compartment.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Karl Schlenker is Vice President of Minnesota Thermal Science. He graduated with a BA from Rutgers University, NJ, and earned an Executive MBA from the Harvard Business School. With over 20 years’ experience in sales and executive management, he has been successful in major corporations as well as several early stage companies. Karl has led the sales and marketing efforts for six different companies, resulting in the sale or public offering of several of these companies. His vision helped Minnesota Thermal Science introduce Golden Hour technology to market in early 2003.
spacer
Karl Schlenker
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Merck Introduces New Integrated Plug & Play Upstream Development Service

• Adaptive approach to cell line development, analytics and clone selection for emerging biotechs and start-up • Tailored upstream development from a single source reduces time to clinic by 20 percent • Fast-track process reduces timeline by 10 weeks for first pharmacodynamic experiment
More info >>

White Papers

Industrial Security in the Pharmaceutical Sector

COPA-DATA

As an attractive target for cyber attacks, pharmaceutical companies need to understand cyber security, assess weak points and implement the appropriate security measures. This white paper describes some of the most effective industrial security tools pharmaceutical companies have at their disposal in the era of Industry 4.0.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement